miR-129-5p inhibits prostate cancer proliferation via targeting ETV1.

Gao, Ge; Xiu, Dianhui; Yang, Bin; Sun, Daju; Wei, Xin; Ding, Youpeng; Ma, Yanan; Wang, Zhixin

Gao, Ge; Xiu, Dianhui; Yang, Bin; Sun, Daju; Wei, Xin; Ding, Youpeng; Ma, Yanan; Wang, Zhixin.

Afiliación

Gao G; Department of Pathology, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China.
Xiu D; Department of Radiology, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China.
Yang B; Department of Breast Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China.
Sun D; Department of Pathology, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China.
Wei X; Department of Urology, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China, wangzhixin1234@aliyun.com.
Ding Y; Department of Urology, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China, wangzhixin1234@aliyun.com.
Ma Y; Department of Urology, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China, wangzhixin1234@aliyun.com.
Wang Z; Department of Urology, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China, wangzhixin1234@aliyun.com.

Onco Targets Ther ; 12: 3531-3544, 2019.

Article en En | MEDLINE | ID: mdl-31190859

Palabras clave

ETV1; microRNA; proliferation; prostate cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Onco Targets Ther Año: 2019 Tipo del documento: Article